TY - JOUR
T1 - ProNGF, a cytokine induced after myocardial infarction in humans, targets pericytes to promote microvascular damage and activation
AU - Siao, Chia Jen
AU - Lorentz, Christina U.
AU - Kermani, Pouneh
AU - Marinic, Tina
AU - Carter, John
AU - McGrath, Kelly
AU - Padow, Victoria A.
AU - Mark, Willie
AU - Falcone, Domenick J.
AU - Leona, Cohen Gould
AU - Parrish, Diana C.
AU - Habecker, Beth A.
AU - Nykjaer, Anders
AU - Ellenson, Lora H.
AU - Tessarollo, Lino
AU - Hempstead, Barbara L.
PY - 2012/11
Y1 - 2012/11
N2 - Treatment of acute cardiac ischemia focuses on reestablishment of blood flow in coronary arteries. However, impaired microvascular perfusion damages peri-infarct tissue, despite arterial patency. Identification of cytokines that induce microvascular dysfunction would provide new targets to limit microvascular damage. Pro-nerve growth factor (NGF), the precursor of NGF, is a well characterized cytokine in the brain induced by injury. ProNGF activates p75 neurotrophin receptor (p75NTR) and sortilin receptors to mediate proapoptotic responses. We describe induction of proNGF by cardiomyocytes, and p75NTR in human arterioles after fatal myocardial infarction, but not with unrelated pathologies. After mouse cardiac ischemia-reperfusion (I-R) injury, rapid up-regulation of proNGF by cardiomyocytes and p75NTR by microvascular pericytes is observed. To identify proNGF actions, we generated a mouse expressing a mutant Ngf allele with impaired processing of proNGF to mature NGF. The proNGF-expressing mouse exhibits cardiac microvascular endothelial activation, a decrease in pericyte process length, and increased vascular permeability, leading to lethal cardiomyopathy in adulthood. Deletion of p75NTR in proNGF-expressing mice rescues the phenotype, confirming the importance of p75NTR-expressing pericytes in the development of microvascular injury. Furthermore, deficiency in p75NTR limits infarct size after I-R. These studies identify novel, nonneuronal actions for proNGF and suggest that proNGF represents a new target to limit microvascular dysfunction.
AB - Treatment of acute cardiac ischemia focuses on reestablishment of blood flow in coronary arteries. However, impaired microvascular perfusion damages peri-infarct tissue, despite arterial patency. Identification of cytokines that induce microvascular dysfunction would provide new targets to limit microvascular damage. Pro-nerve growth factor (NGF), the precursor of NGF, is a well characterized cytokine in the brain induced by injury. ProNGF activates p75 neurotrophin receptor (p75NTR) and sortilin receptors to mediate proapoptotic responses. We describe induction of proNGF by cardiomyocytes, and p75NTR in human arterioles after fatal myocardial infarction, but not with unrelated pathologies. After mouse cardiac ischemia-reperfusion (I-R) injury, rapid up-regulation of proNGF by cardiomyocytes and p75NTR by microvascular pericytes is observed. To identify proNGF actions, we generated a mouse expressing a mutant Ngf allele with impaired processing of proNGF to mature NGF. The proNGF-expressing mouse exhibits cardiac microvascular endothelial activation, a decrease in pericyte process length, and increased vascular permeability, leading to lethal cardiomyopathy in adulthood. Deletion of p75NTR in proNGF-expressing mice rescues the phenotype, confirming the importance of p75NTR-expressing pericytes in the development of microvascular injury. Furthermore, deficiency in p75NTR limits infarct size after I-R. These studies identify novel, nonneuronal actions for proNGF and suggest that proNGF represents a new target to limit microvascular dysfunction.
UR - http://www.scopus.com/inward/record.url?scp=84871854423&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84871854423&partnerID=8YFLogxK
U2 - 10.1084/jem.20111749
DO - 10.1084/jem.20111749
M3 - Article
C2 - 23091165
AN - SCOPUS:84871854423
SN - 0022-1007
VL - 209
SP - 2291
EP - 2305
JO - Journal of Experimental Medicine
JF - Journal of Experimental Medicine
IS - 12
ER -